Skip to main content
. 2020 Jan 28;10:1332. doi: 10.1038/s41598-020-57930-x

Table 1.

Basis clinical data. *In some patients (38 in test set and 26 in validation set) Pn state remains unknown.

Test set (n = 93) Validation set (n = 41)
Age (years) Median [min -max] 65 [28–84] 67 [47–85]
Sex female 40 (43%) 16 (39%)
male 53 (57%) 25 (61%)
T-Status T0/T1 3 (3%) 3 (7%)
T2 10 (11%) 6 (14%)
T3 71 (76%) 31 (76%)
T4 9 (10%) 0
Nodal State negative 19 (20%) 20 (49%)
positive 74 (80%) 21 (51%)
Metastasis M0 92 (99%) 40 (98%)
M1 1 (1%) 1 (2%)
Pn-State* Pn 0 6 (6%) 2 (5%)
Pn 1 49 (53%) 13 (32%)
Grading* G1 1 (1%) 1 (2%)
G2 68 (73%) 21 (51%)
G3 24 (26%) 8 (20%)
Resection State R0 56 (61%) 34 (83%)
R1 37 (39%) 7 (17%)
Tumor localization Caput 70 (75%) 34 (83%)
Papilla vaterii 14 (15%) 0 (0%)
Corpus 4 (4%) 4 (10%)
Tail 5 (5%) 3 (7%)
Surgery Pylorus preserving partial pancreatectomy 69 (74%) 31 (76%)
Classical partial pancreatoduodenectomy 14 (15%) 1 (2%)
Total pancreatectomy 6 (7%) 5 (12%)
Distal pancreatectomy 4 (4%) 4 (10%)
Preoperative chemotherapy 3 (3%) 7 (17%)